 Angiotensin enzyme inhibitors quality life term quality life implies adverse effects treatment intolerable new parameter patients cardiovascular disease Lessons conditions Karnovsky Index Arthritis Impact Measurement Scale Several investigators questionnaires quality life antihypertensive therapy assessment effect angiotensin enzyme ACE inhibition quality life study white men mild hypertension patients significant improvement months general well-being work performance skills cognitive function improvement methyldopa significant worsening measures depression sexual dysfunction life satisfaction propranolol group improvement cognitive functioning social participation worsening sexual function physical symptoms Diuretic therapy negative impact quality life hypertensive patients captopril propranolol results patient populations pharmacological basis results agents available eg beta-blockers ancillary properties calcium channel blockers selective actions various vascular beds comparative studies agents ACE inhibitors old new interest